Restrictive Management of Neonatal Polycythemia

ABSTRACT

Partial exchange transfusion (PET) is traditionally suggested as treatment for neonates diagnosed with polycythemia. Nevertheless, justification of this treatment is controversial. We evaluated the risk for short-term complications associated with a restrictive treatment protocol for neonatal polycythemia. A retrospective cross-sectional analytical study was conducted. Three treatment groups were defined and managed according to their degree of polycythemia, defined by capillary tube filled with venous blood and manually centrifuged hematocrit: group 1, hematocrit 65 to 69% and no special treatment was recommended; group 2, hematocrit 70 to 75% and intravenous fluids were given and feedings were withheld until hematocrit decreased to <70%; and group 3, hematocrit ≥76% or symptomatic neonates and PET was recommended. During the study period, 190 neonates were diagnosed with polycythemia. The overall rate of short-term complications was 15% (28 neonates). Seizures, proven necrotizing enterocolitis, or thrombosis did not occur in any participating neonates. PET was performed in 31 (16%) neonates. The groups did not differ in their rate of early neonatal morbidities or length of hospitalization. Restrictive treatment for neonatal asymptomatic polycythemia is not associated with an increased risk of short-term complications.

KEYWORDS

Polycythemia - neonate - treatment

REFERENCES

• 1 Gross G P, Hathaway W E, McGaughey H R. Hyperviscosity in the neonate.  J Pediatr. 1973;  82 1004-1012
• 2 Drew J H, Guaran R L, Cichello M, Hobbs J B. Neonatal whole blood hyperviscosity: the important factor influencing later neurologic function is the viscosity and not the polycythemia.  Clin Hemorheol Microcirc. 1997;  17 67-72
• 3 Delaney-Black V, Camp B W, Lubchenco L O et al.. Neonatal hyperviscosity association with lower achievement and IQ scores at school age.  Pediatrics. 1989;  83 662-667
• 4 Rosenkrantz T S, Stonestreet B S, Hansen N B, Nowicki P, Oh W. Cerebral blood flow in the newborn lamb with polycythemia and hyperviscosity.  J Pediatr. 1984;  104 276-280
• 5 Holzman I R, Tabata B, Edelstone D I. Blood flow and oxygen delivery to the organs of the neonatal lamb as a function of hematocrit.  Pediatr Res. 1986;  20 1274-1279
• 6 Linderkamp O, Versmold H T, Riegel K P, Betke K. Contributions of red cells and plasma to blood viscosity in preterm and full-term infants and adults.  Pediatrics. 1984;  74 45-51
• 7 van der Elst C W, Malan A F, de V Heese H. Blood viscosity during fluid infusion in the preterm infant.  S Afr Med J. 1979;  55 211-212
• 8 Oh W. Neonatal polycythemia and hyperviscosity.  Pediatr Clin North Am. 1986;  33 523-532
• 9 Werner E J. Neonatal polycythemia and hyperviscosity.  Clin Perinatol. 1995;  22 693-710
• 10 Wiswell T E, Cornish J D, Northam R S. Neonatal polycythemia: frequency of clinical manifestations and other associated findings.  Pediatrics. 1986;  78 26-30
• 11 Linderkamp O, Nelle M, Kraus M, Zilow E P. The effect of early and late cord-clamping on blood viscosity and other hemorheological parameters in full-term neonates.  Acta Paediatr. 1992;  81 745-750
• 12 Shohat M, Merlob P, Reisner S H. Neonatal polycythemia: I. Early diagnosis and incidence relating to time of sampling.  Pediatrics. 1984;  73 7-10
• 13 Shohat M, Reisner S H, Mimouni F, Merlob P. Neonatal polycythemia: II. Definition related to time of sampling.  Pediatrics. 1984;  73 11-13
• 14 Linderkamp O. Placental transfusion: determinants and effects.  Clin Perinatol. 1982;  9 559-592
• 15 Schimmel M S, Bromiker R, Soll R F. Neonatal polycythemia: is partial exchange transfusion justified?.  Clin Perinatol. 2004;  31 545-553, ix–x
• 16 American Academy of Pediatrics Committee on Fetus and Newborn . American Academy of Pediatrics Committee on Fetus and Newborn: Routine evaluation of blood pressure, hematocrit, and glucose in newborns.  Pediatrics. 1993;  92 474-476
• 17 Acunas B, Celtik C, Vatansever U, Karasalihoglu S. Thrombocytopenia: an important indicator for the application of partial exchange transfusion in polycythemic newborn infants?.  Pediatr Int. 2000;  42 343-347
• 18 Roithmaier A, Arlettaz R, Bauer K et al.. Randomized controlled trial of Ringer solution versus serum for partial exchange transfusion in neonatal polycythaemia.  Eur J Pediatr. 1995;  154 53-56
• 19 Murphy Jr D J, Reller M D, Meyer R A, Kaplan S. Effects of neonatal polycythemia and partial exchange transfusion on cardiac function: an echocardiographic study.  Pediatrics. 1985;  76 909-913
• 20 Rosenkrantz T S. Polycythemia and hyperviscosity in the newborn.  Semin Thromb Hemost. 2003;  29 515-527
• 21 Kliegman R M, Walker W A, Yolken R H. Necrotizing enterocolitis: research agenda for a disease of unknown etiology and pathogenesis.  Pediatr Res. 1993;  34 701-708
• 22 Linderkamp O. Blood viscosity of the neonate.  NeoReviews. 2004;  5 406-415
• 23 Mandelbaum V H, Guajardo C D, Nelle M, Linderkamp O. Effects of polycythaemia and haemodilution on circulation in neonates.  Arch Dis Child Fetal Neonatal Ed. 1994;  71 F53-F54
• 24 Liem K D, Hopman J C, Oeseburg B, de Haan A F, Kollée L A. The effect of blood transfusion and haemodilution on cerebral oxygenation and haemodynamics in newborn infants investigated by near infrared spectrophotometry.  Eur J Pediatr. 1997;  156 305-310
• 25 Linderkamp O, Stadler A A, Zilow E P. Blood viscosity and optimal hematocrit in preterm and full-term neonates in 50- to 500-micrometer tubes.  Pediatr Res. 1992;  32 97-102
• 26 Kumar A, Ramji S. Effect of partial exchange transfusion in asymptomatic polycythemic LBW babies.  Indian Pediatr. 2004;  41 366-372
• 27 Goldberg K, Wirth F H, Hathaway W E et al.. Neonatal hyperviscosity. II. Effect of partial plasma exchange transfusion.  Pediatrics. 1982;  69 419-425
• 28 Black V D, Lubchenco L O, Koops B L, Poland R L, Powell D P. Neonatal hyperviscosity: randomized study of effect of partial plasma exchange transfusion on long-term outcome.  Pediatrics. 1985;  75 1048-1053
• 29 Ozek E, Soll R, Schimmel M S. Partial exchange transfusion to prevent neurodevelopmental disability in infants with polycythemia.  Cochrane Database Syst Rev. 2010;  (1) CD005089